Real-time enrollment status for this acute myeloid leukemia clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 12:55 PM UTC
| NCT Number | NCT06824168 |
| Recruiting Status | Recruiting |
| Condition | Acute Myeloid Leukemia |
| Phase | PHASE2 |
| Target Enrollment | 130 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Daiichi Sankyo |
| Last Updated on CT.gov | June 22, 2026 (Jun 22, 2026) |
As of August 31, 2026: Clinical trial NCT06824168 is currently recruiting participants. This phase2 study for acute myeloid leukemia is actively seeking new participants at 9 locations across the United States. The study is sponsored by Daiichi Sankyo. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06824168 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06824168 was last updated Jun 22, 2026 (June 22, 2026). HelloStudys verifies this status automatically.